132 related articles for article (PubMed ID: 9893631)
21. Human colorectal cancers with an intact p16/cyclin D1/pRb pathway have up-regulated p16 expression and decreased proliferation in small invasive tumor clusters.
Palmqvist R; Rutegârd JN; Bozoky B; Landberg G; Stenling R
Am J Pathol; 2000 Dec; 157(6):1947-53. PubMed ID: 11106567
[TBL] [Abstract][Full Text] [Related]
22. Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters.
Dublin EA; Patel NK; Gillett CE; Smith P; Peters G; Barnes DM
Int J Cancer; 1998 Feb; 79(1):71-5. PubMed ID: 9495362
[TBL] [Abstract][Full Text] [Related]
23. p21 is associated with cyclin D1, p16INK4a and pRb expression in resectable non-small cell lung cancer.
Vonlanthen S; Heighway J; Kappeler A; Altermatt HJ; Borner MM; Betticher DC
Int J Oncol; 2000 May; 16(5):951-7. PubMed ID: 10762631
[TBL] [Abstract][Full Text] [Related]
24. Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas.
Simpson DJ; Frost SJ; Bicknell JE; Broome JC; McNicol AM; Clayton RN; Farrell WE
Carcinogenesis; 2001 Aug; 22(8):1149-54. PubMed ID: 11470742
[TBL] [Abstract][Full Text] [Related]
25. Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma.
Ishikawa T; Furihata M; Ohtsuki Y; Murakami H; Inoue A; Ogoshi S
Br J Cancer; 1998; 77(1):92-7. PubMed ID: 9459151
[TBL] [Abstract][Full Text] [Related]
26. Cyclin D1 expression and retinoblastoma gene protein (pRB) expression in esophageal squamous cell carcinoma.
Ikeguchi M; Sakatani T; Ueta T; Kaibara N
J Cancer Res Clin Oncol; 2001 Sep; 127(9):531-6. PubMed ID: 11570573
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 overexpression in colorectal carcinoma in vivo is dependent on beta-catenin protein dysregulation, but not k-ras mutation.
Wong NA; Morris RG; McCondochie A; Bader S; Jodrell DI; Harrison DJ
J Pathol; 2002 May; 197(1):128-35. PubMed ID: 12081197
[TBL] [Abstract][Full Text] [Related]
28. Correlation of cyclin D1 and Rb gene expression with apoptosis in invasive breast cancer.
de Jong JS; van Diest PJ; Michalides RJ; van der Valk P; Meijer CJ; Baak JP
Mol Pathol; 1998 Feb; 51(1):30-4. PubMed ID: 9624417
[TBL] [Abstract][Full Text] [Related]
29. Cyclin D1 and retinoblastoma protein expression in oesophageal squamous cell carcinoma.
Chetty R; Chetty S
Mol Pathol; 1997 Oct; 50(5):257-60. PubMed ID: 9497916
[TBL] [Abstract][Full Text] [Related]
30. Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins.
Hedberg Y; Ljungberg B; Roos G; Landberg G
Int J Cancer; 2004 Mar; 109(2):189-93. PubMed ID: 14750168
[TBL] [Abstract][Full Text] [Related]
31. Expression of p16 and lack of pRB in primary small cell lung cancer.
Yuan J; Knorr J; Altmannsberger M; Goeckenjan G; Ahr A; Scharl A; Strebhardt K
J Pathol; 1999 Nov; 189(3):358-62. PubMed ID: 10547597
[TBL] [Abstract][Full Text] [Related]
32. Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer.
Ko E; Kim Y; Park SE; Cho EY; Han J; Shim YM; Park J; Kim DH
Lung Cancer; 2012 Aug; 77(2):401-6. PubMed ID: 22534667
[TBL] [Abstract][Full Text] [Related]
33. Cyclin D1 overexpression in thyroid carcinomas: relation with clinico-pathological parameters, retinoblastoma gene product, and Ki67 labeling index.
Basolo F; Caligo MA; Pinchera A; Fedeli F; Baldanzi A; Miccoli P; Iacconi P; Fontanini G; Pacini F
Thyroid; 2000 Sep; 10(9):741-6. PubMed ID: 11041450
[TBL] [Abstract][Full Text] [Related]
34. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
35. p16 and pRb immunohistochemical expression increases with increasing tumour grade in mammary phyllodes tumours.
Karim RZ; Gerega SK; Yang YH; Spillane A; Carmalt H; Scolyer RA; Lee CS
Histopathology; 2010 Jun; 56(7):868-75. PubMed ID: 20497245
[TBL] [Abstract][Full Text] [Related]
36. Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers.
Tanaka H; Fujii Y; Hirabayashi H; Miyoshi S; Sakaguchi M; Yoon HE; Matsuda H
Int J Cancer; 1998 Apr; 79(2):111-5. PubMed ID: 9583722
[TBL] [Abstract][Full Text] [Related]
37. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
[TBL] [Abstract][Full Text] [Related]
38. pRb and Cdk regulation by N-(4-hydroxyphenyl)retinamide.
Panigone S; Debernardi S; Taya Y; Fontanella E; Airoldi R; Delia D
Oncogene; 2000 Aug; 19(35):4035-41. PubMed ID: 10962560
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC).
Dworakowska D; Jassem E; Jassem J; Boltze C; Wiedorn KH; Dworakowski R; Skokowski J; Jaśkiewicz K; Czestochowska E
J Cancer Res Clin Oncol; 2005 Jul; 131(7):479-85. PubMed ID: 15809880
[TBL] [Abstract][Full Text] [Related]
40. Loss of pRB in Conjunctival Squamous Cell Carcinoma: A Predictor of Poor Prognosis.
Chauhan S; Sen S; Sharma A; Kashyap S; Tandon R; Pushker N; Vanathi M; Chauhan SS
Appl Immunohistochem Mol Morphol; 2018 Jul; 26(6):e70-e76. PubMed ID: 29489511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
